Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.3950
0.00 (0.00%)
May 21, 2026, 2:47 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 10.8 million as of May 22, 2026. Its market cap has increased by 120.70% in one year.
Market Cap
10.80M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 10.80M, an increase of 35.50%. That is a compound annual growth rate of 15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 10.80M | 0.01% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 16.06M |
| Neurotech International | 15.81M |
| AdAlta | 10.62M |
| Immuron | 10.45M |
| Invex Therapeutics | 9.02M |
| Bio-Gene Technology | 8.85M |
| Biotron | 8.11M |
| Tissue Repair | 7.26M |